HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia.

Name: HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia.
Author: Park, Jong-Ho

HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia. — المؤلف: Park, Jong-Ho — Leukemia 20190906

المؤلف: Park, Jong-Ho
النشر: Leukemia 20190906
الوصف: 1439-1450 p.
الموضوعات: Adolescent؛ Adult؛ Aged؛ Aged, 80 and over؛ Apoptosis؛ Biomarkers, Tumor؛ Case-Control Studies؛ Cell Survival